Six-Year Ban: How Ruti Aga's Forged Prescription Ended Her Career

After winning a half marathon in China in March, Ruti Aga's joy quickly turned to bitterness. The 32-year-old Ethiopian marathon runner had taken first place in that race, but a subsequent doping test returned positive for methylprednisolone. Now, the Athletics Integrity Unit (AIU) announced on Thursday that Aga has been banned for six years. The sanction consists of two years for the presence of the substance and four years for tampering. But the real story goes far beyond the substance – it is the story of a forged medical prescription, written by a family member with no medical registration, using an old prescription pad. The first prescription was a forgery, and the clinic was half a story. Ruti Aga was no ordinary runner. She won the 2026 Tokyo Marathon and finished second three times at World Marathon Majors. Her personal best was around 2:18:34, placing her among elite marathoners. But in this case, no performance data has been made public – neither the time of the half marathon she won in China, nor any splits. What is known is that she won the race and that her subsequent test was positive. The AIU investigation found that she used methylprednisolone for a knee injury, but the prescription submitted for it was fake. A technical correction is necessary here, as media reports have misrepresented it. Methylprednisolone is a glucocorticoid, not an anabolic steroid. In the WADA Prohibited List, it falls under class S9 and is prohibited only in-competition, by injection, oral, or rectal routes. This means therapeutic use out-of-competition can be entirely legal, but if residues are present during competition, it is a violation. That is the legal basis of this case – not the type of substance, but the timing and route. According to the investigation, Aga cited a knee injury, common among marathoners. But the prescription she submitted was from a clinic that did not exist. The "doctor" who signed it was a family member with no medical registration. That person claimed to have used an old prescription pad from a former workplace, but the clinic explicitly denied issuing any such prescription. These were three independent verification failures – the clinic's non-existence, the doctor's lack of registration, and the pad's inauthenticity. The AIU stated in its announcement that Aga made false statements during an interview, which proved the tampering charge. This is an interview-based charge, not just document-based. The result: two years for the presence of the substance (because it is a specified substance and intent was not proven), and four years for tampering – six years total. The ban runs from September 10, the date of her provisional suspension. This backdating is a procedural benefit, not a reduction. Her result and prize money from the March race are also likely to be annulled, though the AIU did not explicitly state this. A road race testing window opens at 23:59 the day before the race, so a glucocorticoid injection given days earlier is caught. In my experience, the AIU has seen a rise in tampering charges in East African road running cases in recent years. This case is part of that pattern. When an athlete believes they can hide substance use, they often resort to forged documents – and that is where they get caught. The irony in Aga's case is that if she had genuine medical records, she might have had a defense. Out-of-competition use of glucocorticoids is legal, and with a proper TUE (Therapeutic Use Exemption) or correct washout timing, she could have emerged without any case. But the forgery destroyed that one defense. Given the depth of Ethiopian women's marathon running, an athlete returning at age 38 with a doping stain is effectively unselectable for the national team. This ban is practically the end of her career. Her 2026 Tokyo Marathon win and three Major runner-up finishes remain part of her record, but commercially she is now radioactive – sponsorship in distance running is already thin. No statement has come from the Ethiopian athletics federation. This case is part of a larger pattern in East African road running, where athletes lack a registered team physician and often rely on informal medical support. This case goes beyond the story of a cheating athlete. It is a story of medical governance failure in East African road running. The knee injury is the root cause – injured marathoners face pressure to mask pain to protect appearance-fee income, and glucocorticoids are the cheapest, most available tool. But the medical network around them is informal. The forgery is a consequence of an untreated governance gap, not the cause. The media has created a false narrative by calling the substance a "steroid." It is not an anabolic steroid, and it has no proven endurance benefit. A six-year ban for a glucocorticoid is striking, and it will be used as evidence of AIU rigor or of disproportionate enforcement against African road runners. Both ways. Aga has the option to appeal to CAS (Court of Arbitration for Sport), but overturning a forgery-based finding is difficult. This case shows that AIU enforcement is no longer limited to substance detection – it is moving toward document verification. As AIU scrutiny increases in the Chinese label-race circuit, and the appearance-fee economy collides with the testing economy, more such cases may emerge. The question is: isn't it necessary to provide athletes with proper medical support? The final whistle has blown, but the story is still live.